المؤلفون: Kevin Shee, Jonathan D. Marotti, Brent N. Rexer, Valerie M. Jansen, Simon Mallal, Margaret L Axelrod, Susan R. Opalenik, Todd W. Miller, Riley E. Bergman, Sara M. Tolaney, Roberto Salgado, Ian E. Krop, Sherene Loi, Vandana G. Abramson, Jing Zhou, Sean Mackay, Justin M. Balko, Paula I. Gonzalez-Ericsson, Melinda E. Sanders, Ingrid A. Mayer, Mellissa J. Nixon, Ana C. Garrido-Castro, Joshua Donaldson, Mark A. Pilkinton, Violeta Sanchez, Wyatt J. McDonnell

المصدر: Clin Cancer Res

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Paclitaxel, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Triple Negative Breast Neoplasms, Disease, CD8-Positive T-Lymphocytes, Article, B7-H1 Antigen, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Breast cancer, Albumins, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, medicine, Humans, Aged, Chemotherapy, business.industry, Immunotherapy, Middle Aged, Gene signature, Prognosis, medicine.disease, Neoadjuvant Therapy, Progression-Free Survival, Neoplasm Proteins, Gene Expression Regulation, Neoplastic, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Cytokine secretion, Neoplasm Recurrence, Local, business, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcb791e74b1e7256046bab4264aacd2Test
https://doi.org/10.1158/1078-0432.ccr-19-3685Test

المؤلفون: Burak Gumuscu, Kevin J. Harrington, Hoi-Shen Radcliffe, Lillian L. Siu, Wendy Snyder, Danny Rischin, Beatriz Castelo Fernandez, Ezra E.W. Cohen, Jason Chesney, Anthony Kong, Jonathan D. Cheng, Nicolas Mach

المصدر: Clinical Cancer Research, Vol. 26, No 19 (2020) pp. 5153-5161

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Herpesvirus 1, Human, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, Multicenter trial, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Adverse effect, Aged, ddc:616, Oncolytic Virotherapy, Biological Products, Chemotherapy, Squamous Cell Carcinoma of Head and Neck, business.industry, Middle Aged, medicine.disease, Combined Modality Therapy, Head and neck squamous-cell carcinoma, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Immunotherapy, Neoplasm Recurrence, Local, Talimogene laherparepvec, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e68d707fa9e943a6b37439bfbf54a5aTest
https://doi.org/10.1158/1078-0432.ccr-20-1170Test

المؤلفون: Jeffery S. Russell, Shanmugasundaram Ramkumar, Everett E. Vokes, Robert L. Ferris, Makoto Tahara, Maura L. Gillison, Lisa Licitra, Mark Lynch, Robert I. Haddad, Joël Guigay, Caroline Even, Nabil F. Saba, Kevin J. Harrington, Fernando Concha-Benavente, Jérôme Fayette, Li Li, Peter Brossart, George R. Blumenschein, A. Dimitrios Colevas

المصدر: Clin Cancer Res

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Cetuximab, Article, law.invention, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, medicine, Humans, Neoplasm Metastasis, Survival rate, Aged, Aged, 80 and over, Chemotherapy, Squamous Cell Carcinoma of Head and Neck, business.industry, Immunotherapy, Middle Aged, ErbB Receptors, Survival Rate, Clinical trial, Nivolumab, 030104 developmental biology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a754089cc56f4bc972d5ecdf0accbd84Test
https://doi.org/10.1158/1078-0432.ccr-18-3944Test

المؤلفون: Elizabeth Blackwood, Jennifer O. Lauchle, Rui Zhu, Yuan Chen, Jean-Charles Soria, Srikumar Sahasranaman, Xuyang Lu, Jennifer L. Schutzman, Patricia LoRusso, Elaine Murray, Franklin Peale, Sami Mahrus, Sophie Postel-Vinay, Jeffrey R. Infante, Xiao Ding, Todd M. Bauer, Antoine Hollebecque, Marie Evangelista

المصدر: Clinical Cancer Research. 23:2423-2432

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Nausea, medicine.medical_treatment, Triple Negative Breast Neoplasms, Pharmacology, Neutropenia, Deoxycytidine, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Piperidines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Melanoma, Aged, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Cancer, Middle Aged, medicine.disease, Gemcitabine, 030104 developmental biology, Oncology, Tolerability, Bone marrow suppression, 030220 oncology & carcinogenesis, Checkpoint Kinase 1, Vomiting, Female, medicine.symptom, business, Heterocyclic Compounds, 3-Ring, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c5bc855dc1b1a96d7edd9072a8b2c0Test
https://doi.org/10.1158/1078-0432.ccr-16-1782Test